Константин Викторович Алексеев

Константин Викторович Алексеев

Auto-generated profile, based on publicly available information

Константин Викторович Алексеев

Федеральный исследовательский центр оригинальных и перспективных биомедицинских и фармацевтических технологий

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2022 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
STSERGEY TISHKOV
SERGEY TISHKOV
EBE. V. Blynskaya
E. V. Blynskaya
KAK. V. Alekseev
K. V. Alekseev
VAV. K. Alekseev
V. K. Alekseev
DGD. I. Gavrilov
D. I. Gavrilov
The creation of drugs with an anxiolytic activity, which do not have the main side effects characteristic of drugs of this group, is an important and socially significant task. For its implementation, within the framework of the development of an original drug with an anxiolytic activity, the composition and manufacturing of GML-1 tablets (N-benzyl-N-methyl-1-phenylpyrrolo [1,2-a] pyrazine-3-carboxamide) are being developed.The aim of this article is to study, using a four-factor analysis of variance, the influence of composition factors on the manufacturing properties of GML-1 tablets and the selection of the type, the amount, stage of the disintegrant addition and the type of lubricating excipients used in the technology of wet granulation of GML-1 tablets.Materials and methods. The materials used are: the substance – GML-1 (N-benzyl-N-methyl-1-phenylpyrrolo [1,2-a] pyrazine-3-carboxamide). Excipients: microcrystalline cellulose 101 (MCC 101); polyvinylpyrrolidone (PVP); crospovidone, croscarmellose sodium (CCS), sodium starch glycolate (SSG); magnesium stearate (MS), sodium stearyl fumarate (SSF). To obtain tablet mixtures, wet granulation and tableting with the study of their main pharmaceutical and technological properties was used.Results. Model compositions were developed and their pharmaceutical and technological properties were studied. These results have been analyzed, the degree of these factors’ influence and their interactions have been determined. In most of the cases considered, the interactions of the factors did not cause a significant change in the optimization criteria. With an increase in the amount of a disintegrant, the disintegration time decreased unevenly, so an increase in the amount of these excipients from 4 to 6 mg had a stronger effect than from 2 to 4 mg. Factor B affected the release degree non-linearly. Factor A influenced all the optimization criteria considered, especially a PS release. The best release and disintegration were observed with crospovidone, which was of a particular importance when processing the test results using a generalized desirability method.Conclusion. In view of the conflicting variance analysis results, for particular factors, the resulting values were additionally analyzed using the generalized desirability function. The use of this method made it possible to reduce the conflicting variance analysis results to the most optimal composition.

17 April 2023 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
STSERGEY TISHKOV
SERGEY TISHKOV
EBE. V. Blynskaya
E. V. Blynskaya
KAK. V. Alekseev
K. V. Alekseev
VAV. K. Alekseev
V. K. Alekseev
Quality Risk Management (QRM) is an important aspect of pharmaceutical development in the Quality-by-Design paradigm, since it determines the Design Space, critical quality attributes and critical process attributes.The purpose of this review is to systematize and analyze the main aspects of the QRM system in relation to each element of pharmaceutical development. This review article discusses the following key elements of QRM such as: risk analysis, risk control, risk communication, risk verification. For risk analysis, the advantages and disadvantages of QRM tools such as Preliminary Hazard Analysis, Failure Mode Effects Analysis, Fault Tree Analysis are presented and analyzed, Hazard Operability Analysis and Hazard Analysis and Critical Control Points. In addition, a description of the methods of mathematical planning and design of experiments for pharmaceutical development and QRM is given and their significance for these systems is determined. Elements of QRM such as root cause analysis, brainstorming, and a corrective and preventive action procedure are given as risk control and mitigation tools.In this paper, the main stages of QRM are considered and conclusions are formulated regarding the main advantages and disadvantages of the methods of identification, analysis, control, risk reporting, and the main ways for further improvement of the presented system are proposed.

5 April 2023
Verified
Journal Article
Closed access
VBV. V. Bueva
V. V. Bueva
EBE. V. Blynskaya
E. V. Blynskaya
KAK. V. Alekseev
K. V. Alekseev
STSERGEY TISHKOV
SERGEY TISHKOV
SMS. V. Minaev
S. V. Minaev
Granulation technologies are commonly used in the production of granular powders and tablets. The main purpose of this technology is to obtain granules, due to which the pharmaceutical substance dosing uniformity and an increase in tapped density essential during transportation and storage are achieved. In addition, it allows minimizing dust formation, thus increasing the safety of the production process. The article presents the results of a theoretical study of recent advances in wet granulation technology, namely, a brief description of the modifications of this technology, accompanied by schematic illustrations of the key stages of the process, as well as the advantages and limitations. of these modifications. The prerequisite for the emergence of alternative modifications of wet granulation technology was the limitations associated with the instability of pharmaceutical substances and the desire to reduce the time frame of the manufacturing process.

8 October 2021 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
STSERGEY TISHKOV
SERGEY TISHKOV
EBE. V. Blynskaya
E. V. Blynskaya
KAK. V. Alekseev
K. V. Alekseev
VBV. V. Buyeva
V. V. Buyeva
Introduction. The SeDeM-ODT method is a relatively new method based on expert judgment and pie charts, which reflect 15 main parameters of the suitability of a dosage form for direct compression and dispersibility in the oral cavity.The purpose of the research presented in this article is to study the pharmaceutical substance (API) GK-2 (bis- (N-monosuccinyl-L-glutamyl-L-lysine)hexamethyleneamide) using the SeDeM-method, to determine the direction for the correction of technological properties using excipients and to develop using the presented methods of the composition of tablets GK-2, dispersible in the oral cavity.Materials and methods. Preparation of tablets – manual hydraulic press PRG-50; method for determining flowability (GPM.1.4.2.0016.15, GP XIV, volume 2) – bulk density analyzer (ERWEKA SVM 221), GTB flowability tester (ERWEKA, Germany); crushing strength of tablets (GPM.1.4.1.0011.15, GP XIV, volume 2) – strength analyzer TBF 1000 CopleyScientific® (Great Britain); method for determining disintegration (GPM.1.4.2.0013.15, GP XIV edition, volume 2) – PTZ-S disintegration tester (Pharma Test, Germany); weight loss on drying (GPM.1.2.1.0010.15, GP XIV edition, volume 1) – moisture analyzer Sartorius MA-35 (Sartorius AG, Germany); determination of fractional composition – a vibrating sieve with pore sizes: 850, 600, 425, 300 and 250 microns, is used to determine the particle size distribution; tablet abrasion tester (GPM.1.4.2.0004.15, GP XIV edition, volume 2) – tablet abrasion tester PTF 30 ERA (Pharma Test, Germany); Optical microscopy (GPM.1.2.1.0009.15, GP XIV edition, volume I) – microscope Nicon, Eclipse E 200; digital camera Nicon Ds-Ri2. The data were processed using the SeDeM and SeDeM-ODT methods.Results. Model formulations have been developed containing various types of co-process fillers and a sliding excipient, which have been studied using the main pharmaceutical-technological methods and optical microscopy. Based on the data obtained, SeDeM-ODT diagrams were constructed, in which the parameters were converted into “radii”, reflecting the degree of acceptability for each technological characteristic. In addition, the following factors were calculated from the pie charts: volumetric parameter, compressibility coefficient, flowability parameter, stability coefficient, dosage coefficient, dispersibility coefficient, as well as the index of good pressing, the parametric index and the parametric index of the profile.Conclusion. As a result of the data obtained, the most optimal composition was selected that was acceptable for all the factors under consideration and had the highest values of the parametric index.

30 April 2022 in Химико-фармацевтический журнал
Verified
Journal Article
Closed access
PDF file
STSERGEY TISHKOV
SERGEY TISHKOV
ДГДмитрий Игоревич Гаврилов
Дмитрий Игоревич Гаврилов
ЕБЕвгения Викторовна Блынская
Евгения Викторовна Блынская
КАКонстантин Викторович Алексеев
Константин Викторович Алексеев
ВБВиктория Владимировна Буева
Виктория Владимировна Буева
VVVladimir Pavlovich Vinogradov
Vladimir Pavlovich Vinogradov
Представлен обзор, касающийся особенностей применения математических моделей, описывающих массообменные процессы в технологии нанесения пленочных покрытий. Приводится формула для расчета толщины пленки покрытия для двояковыпуклой таблетки. Описана модель на основе уравнения Фоккера — Планка, определяющая закон распределения покрытых таблеток по массам и позволяющая получить уравнения для расчета средней массы покрытой таблетки, а также дисперсию, и, следовательно, оценить равномерность распределения материала покрытия по таблеткам. Уравнения для массообменных процессов, показанные в обзоре, дают возможность рассчитать такие характеристики, как влажность продукта и влажность воздуха в барабане типа «coater».

29 July 2020
Verified
Journal Article
Closed access
STSERGEY TISHKOV
SERGEY TISHKOV
BVBlynskaya Evgenia Viktorovna Blynskaya Evgenia Viktorovna
Blynskaya Evgenia Viktorovna Blynskaya Evgenia Viktorovna
KAKonstantin Viktorovich Alekseev
Konstantin Viktorovich Alekseev
VBVictoria Vladimirovna Bueva
Victoria Vladimirovna Bueva
AIArtyom Alekseevich Ivanov
Artyom Alekseevich Ivanov
Chewing gum medicinal is one of the most promising dosage forms for medicines from various pharmacological groups. In this article, an assortment analysis of chewing gum medicinal products located on the Russian and foreign pharmaceutical markets is carried out. The main excipients, the technologies for producing chewing gum medicinal products are described and examples of the development of this dosage form for local and systemic use are given. The advantages and disadvantages of chewing gum medicinal products in comparison with other dosage forms are shown, comparative studies reflecting the use of the presented dosage form are demonstrated. In addition, promising groups of pharmaceutical substances have been identified for development in the form of chewing gum medicinal products especially for domestic developers. It is concluded that this dosage form is promising, the advantages and disadvantages of chewing gum medicinal products for local and systemic use.